Advertisement
U.S. Markets closed

CONSUN PHARMA (1681.HK)

HKSE - HKSE Delayed Price. Currency in HKD
8.080-0.420 (-4.94%)
At close: 04:08PM HKT
Currency in HKD

Valuation Measures4

Market Cap (intraday) 7.02B
Enterprise Value 3.67B
Trailing P/E 7.51
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.29
Price/Book (mrq)1.74
Enterprise Value/Revenue 1.23
Enterprise Value/EBITDA 3.55

Trading Information

Stock Price History

Beta (5Y Monthly) 0.62
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 38.780
52 Week Low 34.380
50-Day Moving Average 36.862
200-Day Moving Average 36.021

Share Statistics

Avg Vol (3 month) 34.39M
Avg Vol (10 day) 33.15M
Shares Outstanding 5825.89M
Implied Shares Outstanding 6N/A
Float 8447.49M
% Held by Insiders 144.65%
% Held by Institutions 16.34%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.6
Forward Annual Dividend Yield 47.43%
Trailing Annual Dividend Rate 30.55
Trailing Annual Dividend Yield 36.46%
5 Year Average Dividend Yield 46.88
Payout Ratio 440.38%
Dividend Date 3N/A
Ex-Dividend Date 4Sep 05, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 30.54%
Operating Margin (ttm)32.87%

Management Effectiveness

Return on Assets (ttm)10.49%
Return on Equity (ttm)22.16%

Income Statement

Revenue (ttm)2.74B
Revenue Per Share (ttm)3.44
Quarterly Revenue Growth (yoy)13.30%
Gross Profit (ttm)N/A
EBITDA 955.46M
Net Income Avi to Common (ttm)836.4M
Diluted EPS (ttm)1.130
Quarterly Earnings Growth (yoy)14.90%

Balance Sheet

Total Cash (mrq)3.58B
Total Cash Per Share (mrq)4.34
Total Debt (mrq)515.42M
Total Debt/Equity (mrq)12.91
Current Ratio (mrq)3.06
Book Value Per Share (mrq)4.48

Cash Flow Statement

Operating Cash Flow (ttm)915.34M
Levered Free Cash Flow (ttm)574.46M